吞嚥障碍管理市场－全球产业规模、份额、趋势、机会、预测：按产品、适应症、分销管道、地区和竞争格局划分，2021-2031年

全球吞嚥困难管理市场预计将从 2025 年的 42.8 亿美元成长到 2031 年的 61.3 亿美元，复合年增长率为 6.17%。

此领域涵盖旨在诊断、治疗和支持吞嚥困难患者的医疗产品和服务，主要产品包括营养增稠剂、改善食物质地的食品、餵食管和必要的诊断设备。市场成长的主要驱动因素是全球人口老化以及中风和帕金森氏症等神经系统疾病发病率的上升。根据美国言语语言听力协会 (ASHA) 预测，到 2024 年，美国将有约 1,510 万成年人患有吞嚥困难，这凸显了对相关护理的巨大需求。

然而，由于专业营养管理和长期照护的高成本，市场面临许多障碍。不同医疗体系报销政策的不一致，常常限制了人们获得必需营养补充剂和治疗辅助器具的机会。这些经济限制阻碍了成本敏感地区采用高品质的解决方案，从而有效地限制了该行业在全球范围内的发展和普及。

市场驱动因素

全球人口快速老化是吞嚥困难管理市场的主要驱动因素。随着老龄化，肌肉无力、唾液分泌减少等生理机能下降会显着损害吞嚥功能，需要临床介入。这种人口结构变化推动了对改善食物质地食品和旨在预防吸入性肺炎等併发症的诊断筛检的需求。根据日本内务部于2024年9月发布的《2024年日本统计手册》，65岁及以上人口将达到3625万，这将成为专业营养解决方案的主要目标群体，并为护理产品提供稳定的需求基础。

同时，神经系统疾病的增加也推动了市场发展。例如，中风和巴金森氏症常常会损害控制吞嚥的神经通路，需要即时进行管饲或使用增稠剂等干预措施。根据世界卒中组织发布的《2024年全球卒中概况》（2024年1月发布），全球每年新增中风病例超过1220万例，需要康復治疗的患者人数持续增长。此外，根据美国癌症协会统计，解剖恶性肿瘤发生率的上升，包括预计2024年美国新增58,450例口腔癌和咽癌病例，凸显了对先进治疗辅助手段的需求。

市场挑战

与专业营养管理和长期照护相关的高昂费用，以及不一致的保险报销政策，是限制全球吞嚥困难管理市场发展的主要障碍。营养增稠剂、改良食品和肠内营养管等必需产品通常需要持续投入大量资金，而这些费用往往无法完全由医疗保险所涵盖。在患者必须自费的地区，高品质管理方案的采用率显着降低。这种经济负担迫使医疗服务提供者和患者家庭选择疗效较差但成本较低的替代方案，这直接阻碍了收入成长和先进吞嚥困难产品的市场渗透。

联邦政府削减临床服务经费进一步加剧了这种经济压力。据美国言语语言听力协会 (ASHA) 称，2024 年最终确定的联邦医疗保险 (Medicare) 医生报销方案将转换係数降低了约 3.4%，实际上降低了言语语言治疗服务的报销率。此类报销削减迫使医疗机构节约营运预算，限制了其投资先进诊断设备和全面长期营养治疗的能力。因此，市场环境趋于僵化，迫使医疗服务提供者优先考虑财务永续性，而非实施专业的管理解决方案。

市场趋势

3D列印质地可控食品的出现正在改变市场格局，满足了人们对美味安全营养摄取的需求。与传统的食物泥食物不同，3D列印技术能够客製化食物结构，使其模拟日常膳食，同时保持安全吞嚥所需的精确质地。这项创新提高了患者的治疗依从性，并使其能够在医疗机构中实现工业化应用。根据3DPrint.com网站2024年4月刊报道，“胃肠病学开始为吞嚥困难患者工业化生产3D列印食品”，胃肠病学公司已开始为医疗机构工业化生产这些特殊产品，日产量达700公斤。这种向自动化且外观精美的营养输送方式的转变，标誌着与传统家庭自製混合餐食的重大变革。

同时，穿戴式生物回馈疗法和神经刺激设备的研发正推动治疗重点从被动管理转向主动復健。这些技术能够恢復神经性吞嚥困难患者的神经控制功能，提供根治性治疗而非暂时性补偿。这一趋势的驱动力在于对吞嚥困难根本原因的设备进行了大量投资。根据《亚太生物製药》（BioPharma APAC）2024年3月刊报道，“Phagenesis完成4200万美元D轮资金筹措，助力吞嚥困难治疗创新”，Phagenesis已完成4200万美元资金筹措。这些进展表明，人们越来越关注能够改善长期復原效果的介入性技术。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球吞嚥障碍治疗市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（药品、肠内营养管、营养补充品）
  • 适应症（口腔和咽部吞嚥困难、食道吞嚥困难）
  • 分销通路（医院药局、零售药局、药局、专科诊所）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美吞嚥障碍管理市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲吞嚥障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区吞嚥障碍管理市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲吞嚥障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲吞嚥障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球吞嚥障碍管理市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Eisai Co. Ltd
• Becton, Dickinson, and Company
• Hormel Health Labs
• AstraZeneca Plc
• Cipla Ltd
• Nestle Health Science
• Kent Precision Food Group Inc.
• Bracco Diagnostics Inc.
• Phagenesis Ltd
• Cook medical Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dysphagia Management Market is projected to expand from USD 4.28 Billion in 2025 to USD 6.13 Billion by 2031, registering a CAGR of 6.17%. This sector encompasses medical products and services designed to diagnose, treat, and support individuals experiencing swallowing difficulties, with key offerings including nutritional thickeners, texture-modified foods, feeding tubes, and essential diagnostic equipment. Market growth is largely driven by the aging global population and the increasing incidence of neurological disorders such as stroke and Parkinson's disease. According to the American Speech-Language-Hearing Association, approximately 15.10 million adults in the United States were affected by dysphagia in 2024, highlighting the critical demand for care.

However, the market faces significant hurdles due to the high costs associated with specialized nutrition and long-term management. Inconsistent reimbursement policies across various healthcare systems frequently restrict access to essential feeding devices and therapeutic aids. These financial constraints often hinder the adoption of premium solutions in cost-sensitive regions, effectively limiting the broader development and penetration of the global industry.

Market Driver

The rapidly aging global population acts as a primary catalyst for the dysphagia management market. As individuals age, physiological declines such as muscle weakness and reduced saliva production significantly impair swallowing functions, necessitating clinical intervention. This demographic shift fuels demand for texture-modified foods and diagnostic screenings to prevent complications like aspiration pneumonia. According to the 'Statistical Handbook of Japan 2024' released by the Ministry of Internal Affairs and Communications in September 2024, the population aged 65 and over reached 36.25 million, representing a substantial target demographic for specialized nutritional solutions and ensuring a steady baseline of demand for long-term care products.

Simultaneously, the rising prevalence of neurological disorders propels market momentum. Conditions such as stroke and Parkinson's disease often disrupt the neural pathways controlling deglutition, requiring immediate interventions via feeding tubes and thickening agents. The World Stroke Organization's 'Global Stroke Fact Sheet 2024' noted in January 2024 that over 12.2 million new strokes occur annually worldwide, creating a continuous influx of patients requiring rehabilitation. Additionally, the increasing incidence of anatomical malignancies, such as the estimated 58,450 new cases of oral cavity and pharyngeal cancer in the United States in 2024 per the American Cancer Society, underscores the necessity for advanced therapeutic aids.

Market Challenge

The high expense associated with specialized nutrition and prolonged care, coupled with inconsistent reimbursement policies, serves as a primary obstacle restricting the Global Dysphagia Management Market. Essential products such as nutritional thickeners, modified texture foods, and feeding tubes often carry significant ongoing costs that are not fully covered by healthcare insurance schemes. In regions where patients must bear these expenses out-of-pocket, the adoption of premium management solutions is markedly lower. This financial burden forces healthcare providers and families to opt for less effective, lower-cost alternatives, thereby directly stalling revenue growth and the broader penetration of advanced dysphagia products.

This economic pressure is further intensified by reductions in federal funding for clinical services. According to the American Speech-Language-Hearing Association, in 2024, the Medicare Physician Fee Schedule finalized a conversion factor reduction of approximately 3.4%, which effectively lowered the reimbursement rates for speech-language pathology services. Such cuts in compensation compel medical facilities to restrict their operational budgets, limiting their ability to invest in sophisticated diagnostic equipment or comprehensive long-term nutritional therapies. Consequently, the market faces stunted expansion as providers prioritize financial viability over the procurement of specialized management solutions.

Market Trends

The emergence of 3D-printed texture-modified foods is transforming the market by addressing the need for palatable, safe nutrition. Unlike traditional pureed meals, 3D printing allows for customized food structures that mimic regular meals while maintaining the precise consistency required for safe swallowing. This innovation improves patient compliance and enables industrial scalability for healthcare institutions. According to 3DPrint.com, April 2024, in the article 'Gastronology Launches Industrial Production of 3D Printed Food for Dysphagia Patients', Gastronology commenced industrial production of these specialized products with a daily capacity of 700 kilograms to serve healthcare facilities. This shift toward automated, visually appealing nutrition represents a significant departure from conventional home-blended diets.

Simultaneously, the development of wearable biofeedback and neurostimulation devices is shifting focus from passive management to active rehabilitation. These technologies restore neural control in patients with neurogenic dysphagia, offering curative therapies rather than temporary compensation. This trend is driven by substantial investment in devices targeting the underlying causes of swallowing disorders. According to BioPharma APAC, March 2024, in the article 'Phagenesis Secures $42M in Series D Funding to Revolutionize Swallowing Dysfunction Treatment', Phagenesis closed a $42 million investment round to accelerate the commercialization of its Phagenyx neurostimulation system. Such advancements highlight a growing focus on interventional technologies that improve long-term recovery outcomes.

Key Market Players

• Eisai Co. Ltd
• Becton, Dickinson, and Company
• Hormel Health Labs
• AstraZeneca Plc
• Cipla Ltd
• Nestle Health Science
• Kent Precision Food Group Inc.
• Bracco Diagnostics Inc.
• Phagenesis Ltd
• Cook medical Inc.

Report Scope

In this report, the Global Dysphagia Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dysphagia Management Market, By Product

• Drug
• Feeding Tubes
• Nutritional solutions

Dysphagia Management Market, By Indication

• Oropharangeal Dysphagia
• Esophageal Dysphagia

Dysphagia Management Market, By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Drug store
• Specialty clinics

Dysphagia Management Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dysphagia Management Market.

Available Customizations:

Global Dysphagia Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dysphagia Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Drug, Feeding Tubes, Nutritional solutions)
  • 5.2.2. By Indication (Oropharangeal Dysphagia, Esophageal Dysphagia)
  • 5.2.3. By Distribution Channel (Hospital pharmacies, Retail pharmacies, Drug store, Specialty clinics)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Dysphagia Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dysphagia Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Dysphagia Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Dysphagia Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Distribution Channel

7. Europe Dysphagia Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dysphagia Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Dysphagia Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Dysphagia Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Dysphagia Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Dysphagia Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Dysphagia Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dysphagia Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Dysphagia Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Dysphagia Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Dysphagia Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Dysphagia Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Dysphagia Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dysphagia Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Dysphagia Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Dysphagia Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Distribution Channel

10. South America Dysphagia Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dysphagia Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Dysphagia Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Dysphagia Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dysphagia Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Eisai Co. Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson, and Company
• 15.3. Hormel Health Labs
• 15.4. AstraZeneca Plc
• 15.5. Cipla Ltd
• 15.6. Nestle Health Science
• 15.7. Kent Precision Food Group Inc.
• 15.8. Bracco Diagnostics Inc.
• 15.9. Phagenesis Ltd
• 15.10. Cook medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer